Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation
Circulation · 23.04.2024 · 149 (17) · 1341-1353
DOI: 10.1161/circulationaha.123.065298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 23.04.2024. Verfasst von Lija Swain und 18 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiology Research Institute, Interventional Research Laboratories, and The Cardiovascular Center, Tufts Medical Center. Hauptthemen laut MEDLINE: Cardiolipins, Extracorporeal Membrane Oxygenation, Myocardial Reperfusion Injury, Myocardial Infarction. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cardiolipin is a mitochondrial-specific phospholipid that maintains integrity of the electron transport chain (ETC) and plays a central role in myocardial ischemia/reperfusion injury. Tafazzin is an enzyme that is required for cardiolipin maturation. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) use to provide hemodynamic support for acute myocardial infarction has grown exponentially, is associated with poor outcomes, and is under active clinical investigation, yet the mechanistic effect of VA-ECMO on myocardial damage in acute myocardial infarction remains poorly understood. We hypothesized that VA-ECMO acutely depletes myocardial cardiolipin and exacerbates myocardial injury in acute myocardial infarction. METHODS: We examined cardiolipin and tafazzin levels in human subjects with heart failure and healthy swine exposed to VA-ECMO and used a swine model of closed-chest myocardial ischemia/reperfusion injury to evaluate the effect of VA-ECMO on cardiolipin expression, myocardial injury, and mitochondrial function. RESULTS: Cardiolipin and tafazzin levels are significantly reduced in the left ventricles of individuals requiring VA-ECMO compared with individuals without VA-ECMO before heart transplantation. Six hours of exposure to VA-ECMO also decreased left ventricular levels of cardiolipin and tafazzin in healthy swine compared with sham controls. To explore whether cardiolipin depletion by VA-ECMO increases infarct size, we performed left anterior descending artery occlusion for a total of 120 minutes followed by 180 minutes of reperfusion in adult swine in the presence and absence of MTP-131, an amphipathic molecule that interacts with cardiolipin to stabilize the inner mitochondrial membrane. Compared with reperfusion alone, VA-ECMO activation beginning after 90 minutes of left anterior descending artery occlusion increased infarct size (36±8% versus 48±7%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Cardiology Research Institute, Interventional Research Laboratories, and The Cardiovascular Center, Tufts Medical Center.
ORCID-Profile: Lija Swain, Shreyas Bhave, Lara Reyelt, Rahul Raghav, Peter S Natov, Masashi Kawabori, Michael T Chin, Navin K Kapur
Förderung
- American Heart Association-American Stroke Association
- NHLBI NIH HHS
Zitieren
APA
Swain, L., Bhave, S., Qiao, X., Reyelt, L., Everett, K. D., Awata, J., Raghav, R., Powers, S. N., Sunagawa, G., Natov, P. S., Mahmoudi, E., Warner, M., Couper, G., Kawabori, M., Miyashita, S., Aryaputra, T., Huggins, G. S., Chin, M. T., & Kapur, N. K. (2024). Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation. Circulation, 149(17), 1341-1353. https://doi.org/10.1161/circulationaha.123.065298
Vancouver
Swain L, Bhave S, Qiao X, Reyelt L, Everett KD, Awata J, et al. Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation. Circulation. 2024;149(17):1341-1353. doi:10.1161/circulationaha.123.065298
BibTeX
@article{Swain2024,
author = {Swain, Lija and Bhave, Shreyas and Qiao, Xiaoying and Reyelt, Lara and Everett, Kay D and Awata, Junya and Raghav, Rahul and Powers, Sarah N and Sunagawa, Genya and Natov, Peter S and Mahmoudi, Elena and Warner, Mary and Couper, Greg and Kawabori, Masashi and Miyashita, Satoshi and Aryaputra, Tejasvi and Huggins, Gordon S and Chin, Michael T and Kapur, Navin K},
title = {Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation},
journal = {Circulation},
year = {2024},
volume = {149},
number = {17},
pages = {1341--1353},
doi = {10.1161/circulationaha.123.065298}
}
EUVIMED